← Back to news

Markets

What $4,500 a Month Really Looks Like in Retirement at Age 62

Y

Tempus AI (TEM) Launches ArteraAI Prostate Test, The First Externally Developed Digital Pathology Algorithm

Y

AeroVironment (AVAV) Expands Its AV Halo Software Platform With Two New Additions

Y

Recursion Pharmaceuticals (RXRX) Hits 52-Week Low; Is It In Oversold Territory?

Y

How a $450,000 Portfolio Could Deliver $31,500 a Year While Limiting Market Drawdowns

Y

Why Is Serve Robotics (SERV) One Of The Most Oversold AI Stocks?

Y

Is Klaviyo (KVYO) One Of The Most Oversold AI Stocks?

Y

Analysts See 124.7% Upside In Stereotaxis (STXS); Find Out Why

Y

Pony AI (PONY) Hits 52-Week Low Following 40% YTD Loss; Is It Oversold?

Y

Knightscope (KSCP) Announces Approximately $3.8 Million In New And Recurring Contracts Across Eight Verticals

Y

Why This Couple Shouldn’t Pay Off Their $475K Mortgage (Even With $175K Cash)

Y

Micron Stock is Up over 133% From Its Lows - But Is MU Still Undervalued?

Y

Palantir Is 1 of the Fastest-Growing AI Companies, but Does That Make It a Buy?

Y

It’s China’s Answer to a Rolls-Royce—and It’s Stuffed With Gadgets

Y

Bond strategists warn yields to stay high even if Iran war ends

Y

'There's mania': Strategists weigh in on looming SpaceX IPO

Y

‘Mr. Buffett, how can I make $30 billion?’: Warren Buffett revealed 3 simple investing rules he lives by

Y

The Ultimate Dividend Stock to Buy With $1,000 Right Now

Y

When to Claim Social Security -- the Subtle Factors That Could Make a Big Difference in Your Perfect Claiming Age

Y

Amylyx Stock: Why the Full Pipeline Story Matters

Y

China tech plays to ride out macro volatility

F

He has $19K in savings but owes $13K across 6 credit cards — and the interest is costing him $2,700 a year

Y

2 Dividend Stocks to Hold for the Next 20 Years

Y

Hyperscaler Debt Flood Brings Derivatives Bonanza

Y

Mastercard vs. Visa: Which Payments Giant Has the Edge?

Y

This $25 Nuclear Stock Could Turn $10,000 Into a Fortune

Y

Nvidia Is Going To Have To Do An Apple On Dividends, Says Jim Cramer: Sounds 'Boring' But It Works

Y

'What If I Need It Later?' — A 46-Year-Old Has A Hard Time Spending After A Lifetime Of Saving

Y

Sickly Healthcare Stocks Are Perking Up. For Contrarian Investors, Buying Now Could Be Just the Remedy to Protect Your Portfolio.

Y

Scenes from the Memorial Day investing road: Takeaways on Walmart, Nvidia, and GameStop

Y

PDI Is Yielding 15.93% After The Drop, And I Believe It's An Opportunity For Income Investors

S

Nvidia: Market's Skepticism Creates A Massive Mispricing

S

Intuitive Machines Wins 2 NASA Contracts, Neither of Which Matters Much

Y

Gates' foundation sold all of its Microsoft shares. Bill Ackman is loading up on the stock. What is Wall Street missing?

Y

SpaceX's IPO charts reveal a company spending like an AI giant: Chart of the Day

Y

Instead of Chasing Alpha, Here Are 4 Ways to Pick the Low-Hanging Apples

Y

Get Paid To Wait: Best 5%+ High-Yield Stocks For Volatile Markets

S

Is BP p.l.c. (BP) among the Best Natural Gas Stocks to Buy for Transitional Power?

Y

Here is why Canadian Natural Resources Limited (CNQ) is among the Best Natural Gas Stocks to Buy for Transitional Power

Y

Ecopetrol S.A. (EC): 9 Best Natural Gas Stocks to Buy for Transitional Power

Y

Enterprise Products Partners (EPD) Gets A Higher Target But Analysts Stay Cautious

Y

Why Shell’s (SHEL) Capital Return Strategy Is Back In Focus

Y

Equinor (EQNR) Lands An Upgrade As Europe’s Gas Market Tightens

Y

Why Exxon Mobil’s (XOM) Board Proposals Are Drawing Investor Attention

Y

Enbridge (ENB) Gets A Higher Target As Its Cash Flow Story Remains Intact

Y

Energy Transfer (ET) Gets A Higher Target As EBITDA Outlook Improves

Y

Is Citius Pharmaceuticals, Inc. (CTXR) among the Best Rated Penny Stocks to Buy According to Wall Street Analysts?

Y

Here is why NRx Pharmaceuticals, Inc. (NRXP) is among the Best Rated Penny Stocks to Buy According to Wall Street Analysts

Y

VolitionRx Limited (VNRX): 7 Best Rated Penny Stocks to Buy According to Wall Street Analysts

Y

eHealth (EHTH) Gets A Higher Target As Operational Momentum Improves

Y